NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, 410078, Hunan, China.
Mol Med. 2023 Feb 6;29(1):20. doi: 10.1186/s10020-023-00616-7.
Fibroblasts are highly heterogeneous mesenchymal stromal cells, and different fibroblast subpopulations play different roles. A subpopulation of fibroblasts expressing CD90, a 25-37 kDa glycosylphosphatidylinositol anchored protein, plays a dominant role in the fibrotic and pro-inflammatory state. In this review, we focused on CD90 fibroblasts, and their roles and possible mechanisms in disease processes. First, the main biological functions of CD90 fibroblasts in inducing angiogenesis and maintaining tissue homeostasis are described. Second, the role and possible mechanism of CD90 fibroblasts in inducing pulmonary fibrosis, inflammatory arthritis, inflammatory skin diseases, and scar formation are introduced, and we discuss how CD90 cancer-associated fibroblasts might serve as promising cancer biomarkers. Finally, we propose future research directions related to CD90 fibroblasts. This review will provide a theoretical basis for the diagnosis and treatment CD90 fibroblast-related disease.
成纤维细胞是高度异质性的间充质基质细胞,不同的成纤维细胞亚群发挥着不同的作用。一群表达 CD90 的成纤维细胞亚群,即一种 25-37kDa 的糖基磷脂酰肌醇锚定蛋白,在纤维化和促炎状态中起主导作用。在这篇综述中,我们重点关注 CD90 成纤维细胞及其在疾病过程中的作用和可能的机制。首先,描述了 CD90 成纤维细胞在诱导血管生成和维持组织稳态中的主要生物学功能。其次,介绍了 CD90 成纤维细胞在诱导肺纤维化、炎症性关节炎、炎症性皮肤病和瘢痕形成中的作用及其可能的机制,并讨论了 CD90 癌相关成纤维细胞如何可能成为有前途的癌症生物标志物。最后,提出了与 CD90 成纤维细胞相关的未来研究方向。本综述将为 CD90 成纤维细胞相关疾病的诊断和治疗提供理论基础。